rilmenidine has been researched along with Metabolic Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bousquet, P; Ehrhardt, JD; Feldman, J; Fellmann, L; Gasparik, V; Greney, H; Schann, S | 1 |
| Bousquet, P; Gomes, F; Gonçalves-de-Albuquerque, CF; Lessa, MA; Machado, MV; Nascimento, AR; Tibiriçá, E; Vieira, AB | 1 |
| Bogdański, P; Bryl, W; Cymerys, M; Kujawska-Łuczak, M; Miczke, A; Pupek-Musialik, D | 1 |
| Ernsberger, P; Koletsky, RJ; Velliquette, RA | 1 |
| Anichkov, DA; Schastnaya, OV; Shostak, NA | 1 |
| Ernsberger, P; Kossover, R; Previs, SF; Velliquette, RA | 1 |
| Sirotiaková, J; Widimský, J | 1 |
2 trial(s) available for rilmenidine and Metabolic Syndrome
| Article | Year |
|---|---|
[The effect of analysed hypotensive drugs on certain metabolic parameters].
Topics: Adult; Antihypertensive Agents; Diabetes Mellitus, Type 2; Felodipine; Female; Humans; Hyperlipidemias; Hypertension; Hyperuricemia; Indoles; Male; Metabolic Syndrome; Middle Aged; Oxazoles; Rilmenidine | 2003 |
Comparison of rilmenidine and lisinopril on ambulatory blood pressure and plasma lipid and glucose levels in hypertensive women with metabolic syndrome.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure Monitoring, Ambulatory; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Lisinopril; Metabolic Syndrome; Middle Aged; Oxazoles; Prospective Studies; Rilmenidine; Single-Blind Method; Statistics, Nonparametric; Treatment Outcome | 2005 |
5 other study(ies) available for rilmenidine and Metabolic Syndrome
| Article | Year |
|---|---|
Synthesis and biological evaluation of 2-aryliminopyrrolidines as selective ligands for I1 imidazoline receptors: discovery of new sympatho-inhibitory hypotensive agents with potential beneficial effects in metabolic syndrome.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Blood-Brain Barrier; Drug Discovery; Heart Rate; Imidazoline Receptors; Ligands; Metabolic Syndrome; Pyrrolidines; Rats; Rats, Wistar; Structure-Activity Relationship; Sympatholytics | 2015 |
Central Sympathetic Modulation Reverses Microvascular Alterations in a Rat Model of High-Fat Diet-Induced Metabolic Syndrome.
Topics: Adrenergic alpha-Agonists; Animals; Clonidine; Diet, High-Fat; Intravital Microscopy; Male; Metabolic Syndrome; Microcirculation; Microvessels; Muscle, Skeletal; Oxazoles; Rats; Rats, Wistar; Rilmenidine; Sodium Chloride, Dietary; Sympathetic Nervous System; Sympatholytics | 2016 |
The role of I(1)-imidazoline receptors and alpha(2)-adrenergic receptors in the modulation of glucose and lipid metabolism in the SHROB model of metabolic syndrome X.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Benzofurans; Blood Pressure; Disease Models, Animal; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Imidazoles; Imidazoline Receptors; Lipid Metabolism; Male; Metabolic Syndrome; Obesity; Oxazoles; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha-2; Receptors, Drug; Rilmenidine; Yohimbine | 2003 |
Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome X.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Cell Membrane; Cholesterol; Clonidine; Disease Models, Animal; Female; Guanabenz; Hyperlipidemias; Imidazoles; Imidazoline Receptors; Liver; Male; Metabolic Syndrome; Oxazoles; Rats; Rats, Inbred SHR; Receptors, Drug; Rilmenidine; Triglycerides | 2006 |
Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.
Topics: Adult; Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Double-Blind Method; Drug Tolerance; Female; Humans; Hypertension; Insulin; Isradipine; Lipids; Male; Metabolic Syndrome; Middle Aged; Oxazoles; Rilmenidine | 2006 |